Prelude Therapeutics Incorporated (PRLD)
NASDAQ: PRLD · Real-Time Price · USD
0.7974
-0.0120 (-1.48%)
At close: Jul 1, 2025, 4:00 PM
0.8000
+0.0026 (0.33%)
After-hours: Jul 1, 2025, 6:11 PM EDT
Prelude Therapeutics Market Cap
Prelude Therapeutics has a market cap or net worth of $45.02 million as of July 1, 2025. Its market cap has decreased by -78.98% in one year.
Market Cap
45.02M
Enterprise Value
-35.99M
1-Year Change
-78.98%
Ranking
Category
Stock Price
$0.80
Market Cap Chart
Since the IPO on September 25, 2020, Prelude Therapeutics's market cap has decreased from $806.64M to $45.02M, a decrease of -94.42%. That is a compound annual growth rate of -45.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2025 | 45.17M | -35.63% |
| Dec 31, 2024 | 70.17M | -73.80% |
| Dec 29, 2023 | 267.79M | -6.83% |
| Dec 30, 2022 | 287.43M | -50.22% |
| Dec 31, 2021 | 577.35M | -80.97% |
| Dec 31, 2020 | 3.03B | 276.02% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 696.15B |
| Johnson & Johnson | 366.71B |
| AbbVie | 322.03B |
| Novo Nordisk | 304.96B |
| UnitedHealth Group | 280.41B |
| Novartis AG | 235.85B |
| Abbott Laboratories | 233.80B |
| AstraZeneca | 217.42B |